Healthcare & Life Sciences

BaroFold

United States

About

BaroFold develops a pressure-enabled protein manufacturing technology (PreEMT™) to modify and produce protein therapeutics, improving the tolerability, efficacy, and safety of protein-based drugs for biopharma companies and research institutions.

Explore BaroFold's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.